Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19
Condition(s):SARS-CoV Infection; Severe Acute Respiratory Syndrome (SARS) PneumoniaLast Updated:July 28, 2021Completed
Hide Studies Not Open or Pending
Condition(s):SARS-CoV Infection; Severe Acute Respiratory Syndrome (SARS) PneumoniaLast Updated:July 28, 2021Completed
Condition(s):Recurrent MiscarriageLast Updated:July 29, 2020Recruiting
Condition(s):Retinopathy, DiabeticLast Updated:August 11, 2020Recruiting
Condition(s):SARS-CoV Infection; SARS (Severe Acute Respiratory Syndrome)Last Updated:December 8, 2020Recruiting
Condition(s):Refractory Mycoplasma Pneumoniae PneumoniaLast Updated:October 8, 2010Terminated
Condition(s):Benign Mucous Membrane PemphigoidLast Updated:February 9, 2021Active, not recruiting
Condition(s):Progressive Multiple SclerosisLast Updated:July 11, 2013Completed
Condition(s):Coronavirus InfectionLast Updated:May 23, 2022Completed
Condition(s):Acute Graft Versus Host Disease; Intestinal Graft Versus Host DiseaseLast Updated:August 2, 2018Withdrawn
Condition(s):Multiple SclerosisLast Updated:May 12, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.